Abstract
The results of two single-blind studies conducted to evaluate the cognitive and psychomotor effects of eslicarbazepine acetate and oxcarbazepine following single and repeated administration in healthy volunteers are reported. The cognitive and psychomotor evaluation consisted of several computerized and paper-and-pencil measures. Eslicarbazepine acetate and oxcarbazepine had similar overall cognitive profiles and did not cause clinically relevant cognitive impairment. The incidence of adverse events was lower with eslicarbazepine acetate than with oxcarbazepine.
Copyright 2010. Published by Elsevier Inc.
Publication types
-
Randomized Controlled Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Anticonvulsants / pharmacology*
-
Attention / drug effects
-
Blood Pressure / drug effects
-
Carbamazepine / analogs & derivatives*
-
Carbamazepine / pharmacology
-
Cognition / drug effects*
-
Dibenzazepines / pharmacology*
-
Dose-Response Relationship, Drug
-
Drug Administration Schedule
-
Follow-Up Studies
-
Heart Rate / drug effects
-
Humans
-
Learning / drug effects
-
Middle Aged
-
Neuropsychological Tests
-
Oxcarbazepine
-
Psychomotor Performance / drug effects*
-
Reaction Time / drug effects
-
Single-Blind Method
-
Statistics, Nonparametric
-
Young Adult
Substances
-
Anticonvulsants
-
Dibenzazepines
-
Carbamazepine
-
eslicarbazepine acetate
-
Oxcarbazepine